Document is current

Any future updates will be listed below

Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI

Crossref DOI link: https://doi.org/10.1186/s13023-014-0145-1

Published Online: 2014-09-26

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark